What this page shows
In May 2024, Emergent announced plans to close its Baltimore-Bayview and Rockville facilities. A later SEC filing disclosed a June ACAM2000 contract option and a CYFENDUS contract modification announced in July.
The contrast shows why a company's layoff or closure headline should be checked against specific products, facilities and contracts. These events can coexist when the facilities being closed are not the capacity supporting the continuing orders. The next research step is a facility-by-product reconciliation, not an assumption of shortage or misconduct.
Recorded evidence
Limitations & review notes
- Research draft. Conclusions may change; review the sources and limitations before relying on them.
- Research draft: not independently verified and not actively monitored. This is a dated research lead, not a verified conclusion.
- The documents do not establish that the closed sites manufactured the products in the cited orders. Contract options and modifications are not equivalent to cash collected, delivered doses or profit.
SuperSmart← Back to DiscoverDiscover